Ligand, Pharmaceutical Partners L.L.C. deal

LGND's Seragen Inc. subsidiary (Hopkinton, Mass.) sold to Pharmaceutical Partners its royalty rights to Zenapax daclizumab

Read the full 165 word article

How to gain access

Continue reading with a
two-week free trial.